logo-loader
RNS
Feedback PLC

Feedback PLC - Appointment of Non-Executive Director

RNS Number : 0110T
Feedback PLC
15 July 2020
 

Feedback plc

 

Philipp Prince Appointed as Non-Executive Director

 

London, 15 July 2020:  Feedback plc (AIM: FDBK, "Feedback" or the "Company") announces the appointment of Philipp Prince as a new Independent Non-Executive Director, effective immediately.

 

Philipp is a chartered accountant with extensive experience in senior finance roles in both private and listed technology companies. He runs his own financial consultancy business, is a board adviser at Overmore Limited, a marketing technology firm, and recently joined BCB Group Holdings Limited, a financial services challenger, as its non-board CFO.

 

He was previously the CFO of Defenx plc, an AIM-listed mobile cyber security company, where he managed the IPO process, fundraising and investor relations and Interim CFO at Enecsys plc, a private equity backed solar micro-inverter developer. For over 20 years, Philipp worked at BDO LLP, where he was a corporate finance partner from 2002-2013.

 

Rory Shaw, Chairman of Feedback, commented: "Philipp has strong experience within the technology sector, especially fundraising, capital markets and M&A. His input will be invaluable as we look to deliver shareholder value with the rollout of Bleepa to the NHS and other healthcare providers."

 

Philipp Prince added: "Feedback is a great company. Even before the current Coronavirus pandemic, it was clear that Feedback's flagship Bleepa product had great potential in solving communication and patient confidentiality issues within the healthcare sector. I am pleased to have joined the Board having recently participated in the placing. I look forward to working with the management team as we focus on delivering the group's strategic vision."

 

The following information is disclosed pursuant to rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies: 

Full name:

Philipp Nicholas Andre Martin Prince

Age:

51

Shareholding in Feedback:

2,500,000 ordinary shares (equivalent to 0.23 per cent. of the Company's issued share capital)

Current directorships held:

None

Directorships held in the previous 5 years:

Defenx Limited (previously Defenx plc)

 

-Ends-

 

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

 

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

 

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

 

 

Instinctif Partners

Melanie Toyne-Sewell / Phillip Marriage

 

+44 (0)20 7457 2020

feedbackplc@instinctif.com

 

Notes to editors 

 

About Feedback plcwww.fbk.com

 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. 

 

Feedback has launched Bleepa, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa, see www.bleepa.com.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAEXLFSEEEAA
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read